CHRISTUS Health Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2005
NCT00260234
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

CHRISTUS Health | CHRISTUS Santa Rosa Medical Center - San Antonio, TX | CHRISTUS Santa Rosa Transplant Institute, San Antonio, TX | UC CHRISTUS

Active Ingredients

Drugs in Phase 3 Trials (1)

vapreotidum (1 trial)

Drugs in Phase 2 Trials (2)

allogeneic pancreatic islet cells (1 trial)

selenious acid (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 1 (Phase 2)

Esophageal and Gastric Varices (Phase 3)

Hemorrhage (Phase 3)

Hypertension (Phase 3)

Hypertension, Portal (Phase 3)

Varicose Veins (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 3